期刊文献+

2型糖尿病患者血清IGF-1、IGFBP-3及胰岛素水平的变化与结直肠癌关系的研究 被引量:6

Study of serum IGF-1,IGFBP-3 and insulin levels in patients with type 2 diabetes mellitus and their relationship with colorectal cancer
原文传递
导出
摘要 目的研究结直肠癌(CRC)和/或2型糖尿病(T2DM)患者胰岛素样生长因子1(IGF-1)、胰岛素样生长因子结合蛋白3(IGFBP-3)及胰岛素(Ins)水平,并探讨其与结直肠癌发病的关系。方法结直肠癌合并2型糖尿病患者24例为C&D组,2型糖尿病患者排除结直肠癌31例为DM组,结直肠癌患者排除2型糖尿病28例为CRC组,健康自愿者28人为正常对照组(NC组)。检测各组收缩压(SBP)、舒张压(DBP)、空腹血糖(FPG)、餐后血糖(PPG)、空腹胰岛素(Fins)、糖化血红蛋白(HbA1C)、甘油三脂(TG)、总胆固醇(TC)、低密度脂蛋白(LDL-C)及高密度脂蛋白(HDL-C);采用酶联免疫吸附法检测胰岛素样生长因子1(IGF-1)和胰岛素样生长因子结合蛋白(IGFBP3)水平,同时计算体质指数(BMI)、腰臀比(WHR)、胰岛素抵抗指数(HOMA-IRI)及IGF-1/IGFBP-3比值。结果 C&D组FPG、PPG、HbA1C、Fins及HOMA-IRI与CRC组比较差异有统计学意义(P<0.01)。C&D组PPG、TC及HOMA-IRI与DM组比较差异有统计学意义(P<0.05)。C&D组IGF-1和IGF-1/IGFBP-3与DM组比较差异有统计学意义(P<0.01)。多元线性逐步回归分析显示,TC、PPG、IGF-1/IGFBP-3及HOMA-IRI对结直肠癌有影响。结论 CRC患者存在IGF-1和IGF-1/IGFBP-3水平变化;高胆固醇血症、餐后血糖升高和胰岛素抵抗可能参与CRC的发生。 Objective To investigate the levels of serum insulin-like growth factor-1 (IGF-1),IGF binding protein-3 (IGFBP-3) and insulin in patients with colorectal cancer (CRC) and/or type 2 diabetes mellitus (T2DM);and to establish the relationship between the levels of IGF-1,IGFBP-3,insulin and colorectal cancer.Methods 24 patients with CRC and T2DM were recruited as C&D group,another 31 patients with T2DM as DM group.28 patients with CRC as CRC group and 28 normal subjects were selected as the control group (NC).The systolic blood pressure (SBP),diastolic blood pressure (DBP),fasting plasma glucose (FPG),2-hour postprandial glucose (PPG),fasting serum insulin (Fins),hemoglobinA1C (HbA1C),triglyceride (TG),total cholesterol (TC),low density lipoprotein (LDL-C) and high density lipoprotein (HDL-C) were measured.IGF-1 and IGFBP-3 levels were determined using the enzyme-linked immunosorbent assay method.The body mass index (BMI),waist/hip ratio (WHR),homeostasis model assessment-insulin resistant index (HOMA-IRI) and IGF-1/IGFBP-3 ratio were calculated.Results The FPG,PPG,HbA1C,Fins and HOMA-IRI were different between C&D and CRC group,while PPG,TC and HOMA-IRI were different between C&D and DM group.There were statistically significant difference between C&D and DM group in IGF-1 and IGF-1/IGFBP-3.Multiple linear stepwise regression analysis showed that TC,PPG,IGF-1/IGFBP-3 and HOMA-IRI have a correlation with CRC.Conclusion The results suggest that IGF-1 and IGF-1/IGFBP-3 are different in patients with CRC.TC,PPG,IGF1/IGFBP-3 and HOMA-IRI are independent risk factors of CRC patients.
出处 《热带医学杂志》 CAS 2013年第8期957-960,共4页 Journal of Tropical Medicine
基金 深圳市福田区科技局立项项目(FTWS201026)
关键词 结直肠癌 2型糖尿病 胰岛素样生长因子1 胰岛素样生长因子结合蛋白3 colorectal cancer type 2 diabetes mellitus insulin-like growth factor-1 IGF binding protein-3
  • 相关文献

参考文献13

  • 1Shikata K, Ninomiya T, Kiyohara Y.Diabetes mellitus and cancer risk: Review of the epidemiologieal evidence[J].Cancer Sci, 2013,104(1) :9-14.
  • 2Renehan AG,Tyson M,Egger M,et al.Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies [ J ]. Lancet, 2008, 371 (9612 ) : 569-578.
  • 3卢瑜,方勇,王青青,潘宏铭.糖尿病与恶性肿瘤关系的回顾性临床研究[J].中华内分泌代谢杂志,2010,26(3):183-187. 被引量:65
  • 4Ollberding NJ,Cheng I,Wilkens LR,et al.Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study [J].Cancer Epidemiol Biomarkers Prev, 2012,21 (5) : 810-820.
  • 5Neuhouser ML, Platz EA, Till C, et al.Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk : results from the prostate cancer prevention trial [J].Cancer Prey Res (Phila) ,2013,6(2) :91-99.
  • 6秦俭,滕家安,梁远,王仁生,汤春园,冯国生,陈甲信.2型糖尿病合并结直肠癌患者血清IGF-I、IGFBP-3的变化及临床意义[J].广西医科大学学报,2009,26(6):886-888. 被引量:5
  • 7McKeown-Eyssen G.Epidemiology of eolorectal cancer revisited:Are serum triglycerides and/or plasma glucose associated with risk [J ] .Cancer Epidemiol Biomarkers Prey, 1994,3 ( 8 ) : 687- 695.
  • 8Swede H,Rohan TE,Yu H,et al.Number of aberrant crypt loci associated with adiposity and IGF1 bioavailability [J].Cancer Causes Control, 2009,20 ( 5 ) : 653-661.
  • 9Tran TT, Naigamwalla D, Oprescu AI, et al.Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo [J]. Endocrinology, 2006,147 ( 4 ) : 1830-1837.
  • 10Orgel E,Mittelman SD.The links between insulin resistance, diabetes, and cancer[J].Curr Diab Rep, 2013,13 (2) : 213-222.

二级参考文献21

  • 1段琼红,王志刚,朱桂宝,卢祖洵,施侣元,聂绍发.血清IGF-1、IGFBP-3水平和大肠癌关系的Meta分析[J].中华流行病学杂志,2005,26(2):132-134. 被引量:11
  • 2King H,Aubert RE,Herman WH.Global burden of diabetes,1995-2025:prevalence,numerical estimates,and projections.Diabetes Care,1998,21:1414-1431.
  • 3Stovring H,Andersen M,Beck-Nielsen H,et al.Rising prevalence of diabetes:evidence from a Danish pharmacy-epidemiolngical database.Lancet,2003,362:537-538.
  • 4Silverman DT,Schiffman M,Everhart J,et al.Diabetes mellitus,other medical conditions and familial history of cancer as risk factors for pancreatic cancer.Br J Cancer,1999,80:1830-1837.
  • 5Yang YX,Hennessy S,Lewis JD.Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients.Gastroenterology,2004,127:1044-1050.
  • 6Bayram A,Eksi F,Mehli M.Prevalence of hepatitis E virus antibodies in patients with chronic hepatitis B and chronic hepatitis C.Gastroenterology,2008,134:95-101.
  • 7Larsson SC,Mantzoros CS,Wolk A.Diabetes mellitus and risk of breast cancer:a meta-analysis.Int J Cancer,2007,121:856-862.
  • 8Yancik R,Wesley MN,Ries LA,et al.Effect of age and comorbidity in postmenopansal breast cancer patients aged 55 years and older.JAMA,2001,285:885-892.
  • 9Yancik R,Wesley MN,Ries LA,et al.Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients:a population-based study.Cancer,1998,82:2123-2134.
  • 10Meyerhardt JA,Catalano PJ,Haller DG,et al.Impact of diabetes mellitus on outcomes in patients with colon cancer.J Clin Oncol,2003,21:433-440.

共引文献68

同被引文献51

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部